Treatments to Eliminate HIV Reservoirs and Reduce Viral Load

The Institut Pasteur

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 62/566,907, filed Oct 2, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 10,323,289	Treatments to Eliminate HIV Reservoirs and Reduce Viral Load Institut Pasteur In force Term ends Jun 25, 2038 · High confidence	Institut Pasteur	In force	Term ends Jun 25, 2038	Term ends Jun 25, 2038	High confidence
US 10,815,540	Treatments to Eliminate HIV Reservoirs and Reduce Viral Load Institut Pasteur In force Term ends Jun 25, 2038 · High confidence	Institut Pasteur	In force	Term ends Jun 25, 2038	Term ends Jun 25, 2038	High confidence
US 11,384,345	DNA Polymerase Theta Mutants, Methods of Producing These Mutants, and Their Uses Institut Pasteur In force Term ends Sep 20, 2038 · High confidence	Institut Pasteur	In force	Term ends Sep 20, 2038	Term ends Sep 20, 2038	High confidence
US 12,516,302	DNA Polymerase Theta Mutants, Methods of Producing These Mutants, and Their Uses Centre National de la Recherche Scientifique In force Term ends Sep 20, 2038 · Medium confidence	Centre National de la Recherche Scientifique	In force	Term ends Sep 20, 2038	Term ends Sep 20, 2038	Medium confidence
US 11,872,276	Zika Virus Chimeric Polyepitope Comprising Non-Structural Proteins and Its Use in an Immunogenic Composition Institut Pasteur In force Term ends Mar 5, 2039 · Medium confidence	Institut Pasteur	In force	Term ends Mar 5, 2039	Term ends Mar 5, 2039	Medium confidence
US 11,305,003	A Zika Virus Chimeric Polyepitope Comprising Non-Structural Proteins and Its Use in an Immunogenic Composition Institut Pasteur Lapsed Apr 19, 2026 on the fee record Ended Apr 19, 2026 · High confidence	Institut Pasteur	Lapsed Apr 19, 2026 on the fee record	Ended Apr 19, 2026	Ended Apr 19, 2026	High confidence
Application 17/025,110	Treatments to Eliminate HIV Reservoirs and Reduce Viral Load Institut Pasteur Abandoned Abandoned Nov 17, 2022	Institut Pasteur	Abandoned	Abandoned Nov 17, 2022	not computed
Application 17/286,406	Antibodies and Methods for Treatment of Lyssavirus Infection Humabs Biomed S.A. Abandoned Abandoned Mar 18, 2025	Humabs Biomed S.A.	Abandoned	Abandoned Mar 18, 2025	not computed
Application 19/026,085	Antibodies and Methods for Treatment of Lyssavirus Infection Humabs Biomed SA Pending Not granted	Humabs Biomed SA	Pending	Not granted	not computed

9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

5 of these are in force and held by The Institut Pasteur.

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.